Intravenous Labetalol Versus Hydralazine in Preeclampsia

Clinical trial NCT06360601 · UNKNOWN

Trial details

NCT number: NCT06360601
Sponsor: Tanta University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Preeclampsia Severe

Start date: 2024-04-01
Primary completion: 2024-11-20
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.